Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | CD81 | P60033 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1832333 | 1.00 | GRIK1 (0.32) | GRIK1FFAR3LCKFYNCD81 | |
| SCHEMBL6256856 | 0.83 | GRIK1 (0.32) | GRIK1CD81 | |
| SCHEMBL6256860 | 0.83 | GRIK1 (0.32) | GRIK1CD81 | |
| SCHEMBL23250 | 0.79 | GRIK1 (0.47) | GRIK1CD81 | |
| SCHEMBL236096 | 0.79 | GRIK1 (0.35) | GRIK1CD81 | |
| SCHEMBL23252 | 0.79 | GRIK1 (0.47) | GRIK1CD81 | |
| SCHEMBL150232 | 0.77 | CD81 (0.35) | GRIK1CD81 | |
| SCHEMBL27793 | 0.77 | CD81 (0.35) | GRIK1CD81 | |
| Hydrochloric Acid SCHEMBL38657492 | 0.77 | GRIK1 (0.46) | GRIK1CD81 | |
| Ammonia Solution, Strong SCHEMBL27781946 | 0.77 | GRIK1 (0.46) | GRIK1CD81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2011-06-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | DNMT1, TET1, MGMT | GRIK1 1528/4885FFAR3 2588/4885LCK 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.